000963.SZ
000963.SZ
CNE0000011S1
HD MEDICINE
Loading chart...

Company Profile

Huadong Medicine Co., Ltd, together with its subsidiaries, engages in the wholesale and retail of pharmaceutical products in China and internationally. The company operates through Pharmaceutical Manufacturing, Pharmaceutical Distribution, Medical Aesthetics, and Industrial Microbiology segments. It offers Chinese medicine, immunosuppressive agents, endocrine, digestive system, antineoplastic, cardiovascular, antibiotic drugs, medical beauty field, and medical devices, as well as engages in pharmaceutical logistics and industrial microbiology activities. In addition, the company provides formulation filling, technical, transportation and warehousing services. The company has strategic collaboration with Heidelberg Pharma AG to jointly develop Antibody Drug Conjugates (ADCs). Huadong Medicine Co., Ltd was incorporated in 1993 and is headquartered in Hangzhou, China.

Related stocks

000999.SZ
000999.SZ • China
CR SANJIU
24.82 CNY
6.18B USD 1Y -12.3%
2196.HK
2196.HK • China
FOSUN PHARMA
17.87 HKD
6.08B USD 1Y -29.9%
600196.SS
600196.SS • China
SHANGHAI FOSUN PHARMACEUTICAL G
23.89 CNY
9.55B USD 1Y -19.9%
002294.SZ
002294.SZ • China
SALUBRIS
30.93 CNY
5.16B USD 1Y -46.6%
600085.SS
600085.SS • China
BEIJING TONG REN TANG CO
24.28 CNY
4.98B USD 1Y -29.3%
600079.SS
600079.SS • China
HUMANWELL HEALTHCARE (GROUP) CO
19.23 CNY
4.7B USD 1Y -10.1%
000423.SZ
000423.SZ • China
DEEJ
46.68 CNY
4.47B USD 1Y -1.3%
000739.SZ
000739.SZ • China
APELOA PHARMA.
25.4 CNY
4.4B USD 1Y +55.9%

Key Metrics & Overview

Detailed metrics & financial data of the company

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
34.8% p.a.
Max Drawdown (5Y)
-48.5%
Sharpe Ratio (5Y)
-0.19
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (34.8% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -62.5% in the extended horizon.
ende